Patient Overview

Patient: Mohammed

Age: 72 years

Country: Oman

Diagnosis:

• Ischemic stroke (Middle Cerebral Artery territory)
• Left-sided hemiparesis
• Dysarthria
• Chronic atrial fibrillation
• Hypertension
• Left ventricular dysfunction

The patient suffered a severe ischemic stroke in January 2017 following a successful cardiac ablation procedure. According to the hospital medical records, the stroke resulted in significant neurological impairment including paralysis of the left arm and leg, impaired speech, and loss of motor function.

---

Medical History

Before the stroke, Mohammed had a long history of cardiovascular disease including:

• Persistent atrial fibrillation
• Premature ventricular contractions (PVC)
• Hypertension
• Reduced cardiac ejection fraction
• Mild coronary artery disease

Hospital records indicate that after cardiac ablation, the patient developed an acute ischemic stroke affecting the right hemisphere of the brain, causing left-sided weakness and neurological deficits.

---

Patient Condition Before Treatment

At the time of evaluation the patient presented with:

Why Regenerative Therapy Was Recommended

Stroke causes a complex cascade of pathological changes that extend far beyond the initial loss of blood supply. Following an ischemic event, damaged brain tissue undergoes prolonged inflammation, neuronal loss, disruption of neural networks, impaired blood circulation, and degeneration of supporting cells. Even years after a stroke, many patients continue to experience weakness, impaired coordination, muscle spasticity, sensory deficits, and reduced functional independence because the body’s natural regenerative capacity is limited.

For Mohammed, who had chronic neurological deficits following an ischemic stroke, an individualized regenerative medicine protocol was developed to target multiple biological mechanisms involved in tissue repair rather than focusing on a single therapeutic pathway. The objective of the treatment was to create a supportive regenerative environment that may facilitate the repair of injured tissues, enhance cellular communication, promote vascular regeneration, and support neurological recovery.

Unlike conventional rehabilitation, which primarily focuses on improving functional performance through physical therapy, regenerative medicine aims to support the biological processes responsible for tissue healing. The treatment protocol combined several complementary stem cell populations and extracellular vesicles, each selected for their potential role in neurological, muscular, vascular, and metabolic recovery.

Mesenchymal Stem Cells (MSCs – MUSE, Umbilical Cord)

Mesenchymal Stem Cells served as the foundation of the regenerative protocol due to their broad biological activity. These cells are widely investigated for their ability to release growth factors, cytokines, and extracellular signaling molecules that support tissue repair. Rather than replacing damaged tissue directly, MSCs primarily function by creating an environment that promotes healing.

Potential biological functions include:

• Supporting regeneration of damaged tissues
• Modulating inflammatory responses
• Supporting immune system regulation
• Secreting regenerative growth factors
• Promoting angiogenesis and tissue remodeling
• Supporting endogenous repair mechanisms
• Enhancing cellular survival within injured tissues

Neural Crest Stem Cells (NCSCs)

Neural Crest Stem Cells were incorporated to support restoration of the nervous system. These multipotent progenitor cells are investigated for their potential role in neural tissue repair and communication between neurons.

Potential biological functions include:

• Supporting neuronal signaling pathways
• Promoting communication between nerve cells
• Supporting restoration of damaged neural networks
• Improving sensory transmission
• Supporting protein synthesis within neural tissues
• Contributing to neuroplasticity

Neural Exosomes (EXO Neural)

Neural-derived exosomes are nanosized extracellular vesicles naturally released by cells. They contain signaling molecules, proteins, messenger RNA, and microRNA that participate in intercellular communication.

Potential biological functions include:

• Supporting communication between neural cells
• Delivering regenerative signaling molecules
• Promoting cellular repair mechanisms
• Supporting neuronal survival
• Enhancing neuroplasticity
• Supporting functional recovery of damaged neural tissue

Endothelial Stem Cells (MVESCs)

Healthy blood vessels are essential for supplying oxygen and nutrients to recovering brain tissue. Endothelial progenitor cells were included to support vascular regeneration and microcirculation.

Potential biological functions include:

• Supporting angiogenesis
• Promoting vascular repair
• Improving tissue perfusion
• Supporting oxygen delivery
• Enhancing microvascular circulation
• Supporting recovery of ischemic tissues

Cardiac Regenerative Cells ( Cardiomyocytes)

Because the patient’s stroke occurred in the setting of significant cardiovascular disease, regenerative cardiac support was also incorporated into the treatment protocol. Three-dimensional cardiomyocyte preparations were included to support myocardial recovery and improve the biological environment for cardiovascular function.

Potential biological functions include:

• Supporting myocardial tissue regeneration
• Improving cardiac cellular metabolism
• Promoting myocardial repair
• Supporting contractile function
• Enhancing cardiovascular recovery

Progenitor Stem Cells (Prog.SC)

Progenitor stem cells represent an intermediate stage between stem cells and mature specialized cells. These cells possess high proliferative capacity and are intended to support active tissue regeneration.

Potential biological functions include:

• Supporting tissue renewal
• Promoting differentiation into specialized cells
• Enhancing regenerative signaling
• Supporting cellular replacement
• Stimulating healing processes

Myoblasts

Myoblasts are precursor cells involved in skeletal muscle regeneration. Their inclusion was intended to support recovery of muscles affected by long-term neurological impairment.

Potential biological functions include:

• Supporting skeletal muscle repair
• Promoting muscle fiber regeneration
• Improving muscle strength
• Increasing muscular endurance
• Supporting recovery from chronic muscle atrophy

Regenerative Cell Therapy Summary

Cellular Product	Dose	Route of Administration
Cardiomyocytes	40 million cells	Intravenous (IV)
MVESCs (Endothelial Stem Cells)	60 million cells	Intravenous (IV)
Neural Crest Stem Cells (NCSCs)	120 million cells	Intravenous (IV)
Progenitor Stem Cells (Prog.SC)	80 million cells	Intravenous (IV)
Mesenchymal Stem Cells (MSCs – MUSE)	240 million cells	Intravenous (IV)
Neural Exosomes (EXO Neural)	36 billion particles	Intravenous (IV)
Myoblasts	40 million cells	Intravenous (IV)

 

Functional Progress

Following completion of the regenerative therapy program and the subsequent rehabilitation period, Mohammed demonstrated clinically meaningful improvements across several neurological and functional domains. Based on the clinical assessment, the overall functional recovery was estimated at approximately 47–50% compared with his pre-treatment condition. The most notable improvements were observed in mobility, muscle control, coordination, and performance of everyday activities.

Although residual neurological deficits remained, the patient showed gradual restoration of motor function and increased independence, indicating an encouraging response to the comprehensive regenerative medicine protocol combined with rehabilitation.

Clinical Parameter	Before Therapy	Follow-Up Assessment
Walking Ability	Walking was significantly limited, requiring considerable effort and assistance for longer distances.	The patient demonstrated a more stable gait, improved endurance, and was able to walk independently for substantially longer distances with increased confidence.
Left Arm Function	Severe weakness with markedly restricted voluntary movement and reduced hand function.	Noticeable recovery of voluntary movement with improved shoulder mobility, better arm control, and partial return of functional hand use during daily activities.
Left Leg Strength	Significant muscle weakness affecting balance and walking stability.	Muscle strength improved considerably, allowing better weight-bearing, enhanced stability, and more coordinated walking.
Balance and Coordination	Poor postural control with increased risk of falls.	Improved balance, smoother body coordination, and greater confidence while standing, walking, and changing direction.
Muscle Spasticity	Persistent muscle stiffness and increased muscle tone limiting movement.	Reduction in muscle stiffness with improved flexibility, greater range of motion, and easier execution of voluntary movements.
Speech	Mild to moderate dysarthria affecting speech clarity.	Speech became clearer and more fluent, with improved articulation and easier communication during conversation.
Functional Independence	Required assistance with several daily activities due to neurological deficits.	Increased independence in personal care and routine daily activities, with reduced reliance on caregiver assistance.
Energy and Physical Endurance	Chronic fatigue, reduced stamina, and decreased physical activity tolerance.	Higher energy levels, improved physical endurance, and increased participation in everyday activities with less fatigue.

Overall Clinical Improvement

The patient’s progress was consistent with gradual neurological recovery following regenerative therapy. Clinical observations suggested improvements in motor control, neuromuscular coordination, muscular endurance, and overall quality of life. The combined regenerative protocol was intended to support the body’s natural repair mechanisms, while ongoing rehabilitation likely contributed to continued functional gains over time.

Estimated overall functional improvement: approximately 47–50%, based on clinical evaluation of mobility, motor function, balance, speech, and independence in activities of daily living. Final clinical outcomes were influenced by the patient’s rehabilitation program, cardiovascular status, and individual regenerative potential.

Conclusion

Mohammed’s case illustrates the challenges of long-term recovery after ischemic stroke and the rationale for using a comprehensive regenerative medicine protocol aimed at supporting neurological repair, vascular regeneration, and functional rehabilitation. As with all regenerative treatments, outcomes depend on multiple factors, including the severity of injury, overall health, rehabilitation, and individual biological response. This case should be interpreted alongside clinical evaluation and long-term follow-up.